Yes, HIV can be passed from a mother to her child during birth. Without any treatment, the risk of transmission during pregnancy, labor, and breastfeeding combined ranges from 15% to 45%. The good news: with proper medical care throughout pregnancy, that risk drops to less than 1%.
How HIV Passes From Mother to Child
HIV can cross from mother to baby at three distinct stages: during pregnancy, during labor and delivery, and after birth through breastfeeding. Labor and delivery carry the highest risk, accounting for more than 50% of all transmission cases when no treatment is used. During labor, the baby’s skin and mucous membranes come into direct contact with the mother’s blood and vaginal fluids as the baby moves through the birth canal. That prolonged exposure creates the main window for the virus to enter the baby’s body.
Transmission during pregnancy itself accounts for roughly 35% of untreated cases. This happens when HIV crosses the placenta. Breastfeeding adds another 7% to 22% risk on its own if the mother isn’t receiving treatment.
How Treatment Lowers the Risk to Under 1%
Antiretroviral therapy taken consistently throughout pregnancy, childbirth, and breastfeeding reduces the chance of passing HIV to a baby to less than 1%. The key factor is the mother’s viral load, which is the amount of virus circulating in her blood. When treatment suppresses the virus to undetectable levels, there is very little virus available to cross to the baby during any stage.
Viral load also determines how the baby is delivered. If the mother’s viral load is above 1,000 copies per milliliter near the time of birth, a scheduled cesarean delivery at 38 weeks is recommended to reduce the baby’s exposure to blood and fluids during labor. When the viral load is well controlled (at or below 1,000 copies), vaginal delivery is considered safe, and a C-section solely to prevent HIV transmission is not recommended.
What Happens for the Baby After Birth
Babies born to mothers with HIV receive preventive medication as soon as possible after delivery, ideally within six hours. The length and intensity of this treatment depend on how likely the baby was to have been exposed. Babies considered at higher risk receive three medications for up to six weeks. Those at lower risk may receive a shorter course of a single medication.
Because babies carry their mother’s antibodies for months after birth, standard HIV antibody tests don’t work for infants. Instead, doctors use specialized tests that detect the virus’s genetic material directly. Testing typically follows a specific schedule: at birth, at 14 to 21 days, at 1 to 2 months, and again at 4 to 6 months. To definitively rule out HIV in a non-breastfed infant, at least two negative tests are needed, with one taken at 1 month or older and another at 4 months or older.
For breastfed babies, testing continues every three months during breastfeeding, with additional tests at 4 to 6 weeks and 4 to 6 months after breastfeeding ends.
Breastfeeding and HIV Risk
Breastfeeding guidelines vary depending on where a mother lives and what resources are available. In settings where clean water and formula are reliably accessible, avoiding breastfeeding has traditionally been recommended to eliminate that route of transmission entirely. In many parts of the world, though, the risks of not breastfeeding (malnutrition, contaminated water, lack of immune protection) can outweigh the small risk of HIV transmission when the mother is on effective treatment.
The World Health Organization recommends that mothers living with HIV who are on consistent antiretroviral therapy should exclusively breastfeed for the first six months, then continue alongside solid foods for at least 12 months and up to 24 months or longer. This guidance applies in settings where health services actively support treatment adherence. When a mother’s viral load stays undetectable throughout breastfeeding, the transmission risk remains below 1%.
Prenatal Screening Makes Prevention Possible
All of these protective steps depend on knowing the mother’s HIV status early. HIV testing is a routine part of prenatal care, and early detection allows treatment to begin well before delivery. Starting antiretroviral therapy during pregnancy gives the medication time to suppress the virus to undetectable levels before the baby faces the highest-risk moment: passing through the birth canal. Women who begin treatment early and maintain it throughout pregnancy have the best outcomes, with transmission rates that are a fraction of a percent.
Even in cases where HIV is discovered late in pregnancy or during labor itself, immediate treatment and a scheduled cesarean delivery can still significantly reduce the risk. The combination of maternal treatment, careful delivery planning, and preventive medication for the newborn has made perinatal HIV transmission largely preventable in settings with access to medical care.